Individuals With Chronic Obstructive Pulmonary Disease Experience Lower Levels of Happiness Than Their Healthy Peers: A Case‐Control Study Authors: Layla Cristine de Toledo, Cristino Carneiro Oliviera, Joice Gomide Nolasco de Assis, Júlia Márcia Pereira, Larissa Guimarães Paiva, Nara Batista de Sousa, Carla Malaguti, Anderson José Published: 2026 ABSTRACT ABSTRACTBackground and AimsChronic obstructive pulmonary disease (COPD) is associated with significant psychological distress, including anxiety and depression, which negatively impact quality of life. While these emotional burdens are well‐documented, little is known about how COPD influences positive psychological states, such as happiness. Therefore, we aimed to evaluate whether individuals with COPD experience lower levels of happiness compared to healthy peers.MethodsThis cross‐sectional case‐control study included 82 participants (41 with clinically stable COPD and 41 healthy controls) matched for age, sex, social class, and economic status. Exclusion criteria included acute health complications, acute COPD exacerbations, or coexisting cardiovascular, neurological, musculoskeletal, or other respiratory diseases. Happiness was assessed using the Subjective Happiness Scale, Cantril Ladder Scale, and Satisfaction with Life Scale, with higher scores representing better happiness status. Statistical comparisons between groups were performed using t‐tests or Mann–Whitney tests, as appropriate, with significance set at p < 0.05.ResultsIndividuals with COPD (23 males; age 69.0 ± 10.3 years), predominantly with moderate to severe airflow limitation, exhibited significantly lower levels of happiness compared to age‐, sex‐, social class, and economically‐matched healthy controls. Median (IQR) scores were consistently lower in the COPD group across all measures: Subjective Happiness Scale, 4.5 (4.2–5.0) versus 6.3 (5.8–7.0); Cantril Ladder Scale, 6.0 (5.0–8.0) versus 8.0 (7.5–9.0); and Satisfaction with Life Scale, 23.0 (18.5–30.0) versus 31.0 (28.0–33.0), with all comparisons reaching statistical significance (p < 0.001) and demonstrating medium to large effect sizes.ConclusionIndividuals with COPD experience significantly lower levels of happiness compared to healthy peers. These findings suggest that positive psychological states are impaired in this population, indicating that the impact of the disease extends beyond traditional measures of distress and may warrant further investigation in clinical practice. Introduction Pulmonary and systemic manifestations associated with chronic obstructive pulmonary disease (COPD) profoundly affect daily life, reduce quality of life, and increase rates of anxiety and depression [1, 2]. Mental health issues related to COPD have consistently been associated with poor prognosis and higher mortality rates [1, 2]. In this context, individuals with COPD often present with a wide range of emotional disturbances, including dissatisfaction with body image, low self‐esteem, diminished self‐confidence, loss of life purpose, loneliness, hopelessness, hypochondria, hysteria, introversion, despair, hostility, guilt, fear, worry, bad moods, apathy, lack of energy, and panic attacks [3, 4, 5]. These negative psychological states can interact with physical symptoms, further compromising overall well‐being. Moreover, acute exacerbations of COPD are experienced as a traumatic event, and symptoms observed were consistent with post‐traumatic stress disorder spectrum [3, 4, 5]. Helplessness has even been identified as a predictive factor for future exacerbations [4], while increased suicide rates in this population highlight a heightened susceptibility to self‐destructive behaviors. Alarmingly, individuals with COPD presented a higher fatality rate in suicide attempts [5]. Together, these findings underscore the considerable psychological vulnerability associated with COPD. Despite the extensive evidence on the emotional burden and negative affect experienced by individuals with COPD, the perception of positive psychological states, particularly happiness, remains largely unexplored. Happiness is increasingly recognized as a distinct indicator of well‐being, integrating emotional, cognitive, and motivational dimensions [6]. Conceptually, happiness is not merely the absence of psychological distress; rather, these represent independent constructs within the “dual‐axis” model of mental health. While traditional measures of anxiety and depression focus on the presence of negative affect, happiness scales capture the presence of positive affect and the subjective appraisal of life quality [6, 7, 8, 9]. Examining these positive states may provide novel insights into how chronic illness influences not only distress but also the capacity to experience positive emotions, which offers unique perspectives for comprehensive patient care in COPD. Therefore, this study aimed to evaluate whether individuals with COPD have a reduced perception of happiness compared with healthy individuals. Methods Study Design and Ethics This was a cross‐sectional case‐control study conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement [10]. The study protocol was approved by the Research Ethics Committee of the University Hospital of the Federal University of Juiz de Fora, Minas Gerais, Brazil (approval no. 6.187.583), and complied with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants before enrollment. Participants Participants were recruited from a general secondary care university hospital in Juiz de Fora, Minas Gerais, Brazil. A convenience sample was used, with participants recruited during clinical visits based on feasibility and availability. No a priori sample size calculation was performed. Eligible individuals were from both sexes, aged 18 years or older, with a confirmed diagnosis of COPD, clinically stable (no exacerbations in the past 4 weeks) [1]. All participants were receiving standard medical care, including optimized pharmacological treatment according to International Guidelines [1]. However, they were not enrolled in any formal pulmonary rehabilitation programs or regular physical exercise. This was required to minimize confounding factors, as regular exercise can enhance positive affect and subjective happiness, ensuring that results primarily reflected the participants’ clinical status and daily living conditions. Exclusion criteria included the presence of acute health complications, acute COPD exacerbations, and coexisting cardiovascular, neurological, musculoskeletal, or other respiratory diseases. The control group comprised healthy individuals matched to the COPD group by sex, age, social class, and economic status. Assessments All assessments were performed at the respiratory rehabilitation unit of the University Hospital by a single, trained researcher using standardized protocols. The sample was characterized by recording sociodemographic status, smoking history, and comorbidities. The impact of symptoms was assessed using the COPD Assessment Test (CAT) [11], and dyspnea was evaluated with the modified Medical Research Council (mMRC) scale [12]. Spirometry was conducted according to International Guidelines [13], and results were expressed as absolute values and percentages of the predicted values [14]. The severity of airway obstruction was classified using the GOLD criteria: GOLD 1 (mild): FEV1 ≥ 80% predicted; GOLD 2 (moderate): 50% ≤ FEV1 < 80% predicted; GOLD 3 (severe): 30% ≤ FEV1 < 50% predicted; and GOLD 4 (very severe): FEV1 < 30% predicted [1]. Economic class was determined using the Brazilian Economic Classification Criteria [15], which combines the educational level of the head of household with household ownership of durable goods. The system categorizes individuals into classes A1−A2 (highest income and consumption, consisting of families with high average monthly income and broad ownership of durable goods), B1–B2 (upper‐middle class, good level of consumption and access to services and education), C (middle class, moderate consumption patterns and some limitations in access to services), and D–E (economically vulnerable, low income, and limited access to essential goods and services) [15]. Exercise capacity was assessed using the six‐minute walk test (6MWT). Two tests were performed with a 30 min rest interval, and the test with the greatest distance was considered for analysis. The outcome was the distance covered and the percentage of the predicted distance [16, 17]. Happiness was assessed using three distinct instruments: –The Subjective Happiness Scale is a questionnaire‐based tool designed to evaluate self‐perceived happiness through four items answered on a 7‐point Likert scale. Total scores range from one to seven, with higher values indicating greater perceived happiness. This scale has demonstrated strong psychometric properties in both its original version and the Brazilian validation [18, 19].–The Cantril Ladder, which requires respondents to rate their happiness evaluation on a “ladder” ranging from 0 (“worst possible life”) to 10 (“best possible life”). This measure is widely recognized and utilized internationally, including in the Gallup World Poll and the World Happiness Report [6, 20].–The Satisfaction with Life Scale, a five‐item questionnaire also rated on a 7‐point Likert scale (with a total range of 5–35), which measures overall life satisfaction; higher scores reflect a greater degree of satisfaction [21]. –The Subjective Happiness Scale is a questionnaire‐based tool designed to evaluate self‐perceived happiness through four items answered on a 7‐point Likert scale. Total scores range from one to seven, with higher values indicating greater perceived happiness. This scale has demonstrated strong psychometric properties in both its original version and the Brazilian validation [18, 19]. The Subjective Happiness Scale is a questionnaire‐based tool designed to evaluate self‐perceived happiness through four items answered on a 7‐point Likert scale. Total scores range from one to seven, with higher values indicating greater perceived happiness. This scale has demonstrated strong psychometric properties in both its original version and the Brazilian validation [18, 19]. –The Cantril Ladder, which requires respondents to rate their happiness evaluation on a “ladder” ranging from 0 (“worst possible life”) to 10 (“best possible life”). This measure is widely recognized and utilized internationally, including in the Gallup World Poll and the World Happiness Report [6, 20]. The Cantril Ladder, which requires respondents to rate their happiness evaluation on a “ladder” ranging from 0 (“worst possible life”) to 10 (“best possible life”). This measure is widely recognized and utilized internationally, including in the Gallup World Poll and the World Happiness Report [6, 20]. –The Satisfaction with Life Scale, a five‐item questionnaire also rated on a 7‐point Likert scale (with a total range of 5–35), which measures overall life satisfaction; higher scores reflect a greater degree of satisfaction [21]. The Satisfaction with Life Scale, a five‐item questionnaire also rated on a 7‐point Likert scale (with a total range of 5–35), which measures overall life satisfaction; higher scores reflect a greater degree of satisfaction [21]. Statistical Analysis All statistical analyses were conducted using IBM SPSS Statistics for Windows, Version 27.0 (IBM Corp., Armonk, NY, USA). Data distribution was first examined using the Shapiro−Wilk test to determine normality. Descriptive statistics were reported as mean ± standard deviation for normally distributed continuous variables, median and interquartile range (IQR) for non‐normally distributed data, and frequency (percentage) for categorical variables. Between‐group comparisons were performed using an independent‐samples t‐test for parametric variables, a Mann–Whitney U test for nonparametric variables, and chi‐square tests for categorical data. To complement significant testing, effect sizes were calculated for nonparametric comparisons using the r statistic derived from the Mann–Whitney U test, and interpreted as small (0.1–0.3), medium (0.3–0.5), or large (> 0.5). All statistical tests were two‐sided, and a p < 0.05 was considered statistically significant [22]. Results Sample Characteristics A total of 82 individuals were included as a convenience sample in the study, consisting of 41 participants with clinically stable COPD and 41 healthy controls. Groups were appropriately matched for age, sex, social class, and economic status. The COPD group had a mean age of 69.0 ± 10.3 years (23 males and 18 females), while the control group had a mean age of 69.4 ± 10.1 years, with an identical sex distribution. Sociodemographic variables—including marital status, religion, education level, and economic classification—did not differ significantly between groups. Regarding disease severity, the COPD sample included seven individuals with mild disease (GOLD 1; 17%), 23 with moderate disease (GOLD 2; 56%), eight with severe disease (GOLD 3; 20%), and three with very severe disease (GOLD 4; 7%). As expected, participants with COPD exhibited a significant impact of symptoms on their health status, reduced exercise capacity, and increased levels of dyspnea. Sociodemographic and clinical characteristics for both groups are summarized in Table 1. Table 1Sample characteristics.COPD group (n = 41)Control group (n = 41) p value Sociodemographic characteristics Age (years)69.0 ± 10.369.4 ± 10.1 p = 0.820BMI (kg/m2)27.9 ± 6.828.3 ± 5.3 p = 0.716SexMale23 (56)23 (56) p > 0.99Female18 (44)18 (44)Marital statusWithout partner22 (53.7)24 (58.5) p = 0.824With partner19 (46.3)17 (41.5)ReligionCatholic33 (80.5)28 (68.3) p = 0.464Pentecostal6 (14.6)10 (24.4)Spiritist2 (4.9)2 (4.9)Others0 (0)1 (2.4)EducationIncomplete elementary16 (39.0)13 (31.7) p = 0.422Elementary14 (34.1)10 (24.4)High school7 (17.1)10 (24.4)College4 (9.8)8 (19.5)Economic classificationa A11 (2.4)1 (2.4) p = 0.883A200B10 (0.0)1 (2.4)B27 (17.1)9 (22.0)C123 (56.1)22 (53.7)C21 (2.4)2 (4.9)D and E9 (22.0)6 (14.6) Clinical and functional characteristics Pulmonary functionFEV1, % pred.59.7 ± 19.2FVC, % pred.69.8 ± 19.6FEV1/FVC67.0 ± 14.4GOLD classificationGOLD 1—mild7 (17)GOLD 2—moderate23 (56)GOLD 3—severe8 (20)GOLD 4—very severe3 (7)Smoking statusFormer smoker39 (95.1)Current smoker2 (4.9)Never smoker2 (4,9)ComorbiditiesHypertension27 (65.9)Diabetes10 (24.4)Cardiovascular disease6 (14.6)CAT17.8 ± 4.8mMRC2 (1–3)mMRC 05 (12)mMRC 113 (32)mMRC 210 (24.5)mMRC 310 (24.5)mMRC 43 (7)Functional status6MWT, m356 ± 1176MWT, % pred.67 ± 23 Note: Data are presented as mean ± standard deviation, median (interquartile range), and frequency (%).Abbreviations: 6MWT, six‐minute walk test; BMI, body mass index; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; mMRC, modified Medical Research Council dyspnea scale. a Economic classification was categorized according to the Brazilian Economic Classification Criteria.John Wiley & Sons, Ltd. Sample characteristics. Note: Data are presented as mean ± standard deviation, median (interquartile range), and frequency (%). Abbreviations: 6MWT, six‐minute walk test; BMI, body mass index; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; mMRC, modified Medical Research Council dyspnea scale. Economic classification was categorized according to the Brazilian Economic Classification Criteria. Happiness Outcomes Compared with healthy controls, individuals with COPD consistently reported lower levels of happiness and life satisfaction. On the Subjective Happiness Scale, the COPD group had a median score of 4.5 (IQR 4.3–5.0) versus 6.3 (IQR 5.8–7.0) in controls (p < 0.001), corresponding to a large effect size (r = 0.673). On the Cantril Ladder, median scores were 6.0 (IQR 5.0–8.0) in the COPD group compared with 8.0 (IQR 7.5–9.0) among controls (p < 0.001), with a medium effect size (r = 0.457). Finally, on the Satisfaction with Life Scale, participants with COPD reported a median score of 23.0 (IQR 18.5–30.0), while healthy peers reported 31.0 (IQR 28.0–33.0) (p < 0.001), also with a medium effect size (r = 0.474). These results are presented in Table 2. Table 2Results and comparison between groups.COPD group (n = 41)Control group (n = 41)Effect size p valueSubjective happiness scale4.5 (4.3–5.0)6.3 (5.8–7.0)0.673 p < 0.001Cantril ladder scale6.0 (5.0–8.0)8.0 (7.5–9.0)0.457 p < 0.001Life satisfaction scale23.0 (18.5–30.0)31.0 (28.0–33.0)0.474 p < 0.001 Note: Data presented as median (interquartile range). Effect size interpreted as small (0.1–0.3), medium (0.3–0.5), or large (> 0.5).John Wiley & Sons, Ltd. Results and comparison between groups. Note: Data presented as median (interquartile range). Effect size interpreted as small (0.1–0.3), medium (0.3–0.5), or large (> 0.5). Discussion To our knowledge, this is the first study to assess perceived happiness among individuals with COPD compared with healthy peers. Our findings indicate that individuals with COPD reported significantly lower levels of subjective happiness and life satisfaction when compared to demographically matched healthy controls. Importantly, the differences were consistent across all validated measures of happiness and satisfaction with life, with medium to large effect sizes, underscoring the robustness of our results. The lower levels of happiness observed in our COPD participants align with recent global data suggesting that chronic physical conditions are among the strongest predictors of reduced life evaluation and positive affect [23]. Modern frameworks of patient‐reported outcomes (PROs) emphasize that capturing these positive psychological states is essential for a comprehensive understanding of the disease burden, as they offer independent information that traditional markers of distress, such as anxiety and depression, may overlook [24]. Our results demonstrate that COPD significantly impacts the positive dimension of mental health, which conceptually reflects the presence of positive emotional experiences and a favorable cognitive appraisal of life, rather than merely the absence of negative symptoms [6, 7, 8, 9]. Thus, assessing positive affect offers a complementary and non‐redundant perspective for comprehensive patient care and caregiver support [7, 8, 9]. The happiness scores observed in the COPD group should be interpreted alongside their multidimensional clinical profile. In addition to airway obstruction, our participants exhibited a significant symptom burden (CAT), persistent dyspnea (mMRC), and reduced exercise capacity (6MWD). These findings describe how physical limitations and symptomatic impact can constrain a patient's daily life, potentially compromising the capacity to maintain positive psychological states. While our cross‐sectional design precludes establishing causality, the presence of these clinical markers provides a comprehensive context for the diminished happiness reported. It remains unclear, however, whether lower happiness levels are a consequence of the disease's progressive limitations. The perceived happiness may reflect a complex interplay between physical limitations, emotional distress, and social constraints commonly experienced by individuals with COPD. Interestingly, while the groups were matched for sociodemographic variables, exploratory inspection of our data suggested that lower happiness scores in the COPD group were consistent across sex, marital status, and economic classifications. Although not powered for subgroup analyses, this pattern indicates that the impact of COPD on happiness may be broad and not restricted to specific demographic strata. These findings align with secondary data from a study which revealed that individuals with COPD report significantly lower levels of perceived happiness [23]. The impact of COPD on happiness becomes even more evident when compared to other chronic conditions. Their self‐reported happiness was inferior to that of individuals living with cancer, hypertension, diabetes, asthma, cardiovascular diseases, arthritis, and stroke [23]. Moreover, participants with COPD demonstrated the lowest scores in perceived control over their lives, reported fewer experiences of feeling relaxed, and had the highest levels of perceived stress when compared to individuals with other chronic health conditions [23]. It is well established that pulmonary function in individuals with COPD is closely associated with health‐related quality of life [25]. However, it remains unclear whether pulmonary function also influences the subjective perception of happiness in this population. The small number of participants in these categories precluded meaningful comparisons. This observation highlights the importance of future studies designed with larger, more balanced samples across GOLD stages to examine whether disease severity gradients are mirrored by differences in perceived happiness. The observed lower levels of happiness among COPD patients provide a rationale for exploring more integrative care models. Rather than focusing solely on the mitigation of negative symptoms, future research should evaluate whether positive psychological resources could enhance patient resilience [8, 9]. These data suggest that positive psychology constructs may be important components to consider in the design of future pulmonary rehabilitation trials, potentially supporting long‐term engagement in health‐promoting behaviors and exercise adherence [26]. Limitations of this study include the use of a convenience sample recruited from a single center, which may limit the generalizability of the findings. Furthermore, no a priori sample size calculation was performed. Additionally, the small representation of participants in the mild and very severe GOLD categories constrained our ability to examine associations between disease severity and happiness. Finally, due to the cross‐sectional design, causal inferences cannot be established. Nevertheless, the consistent findings across three validated happiness measures strengthen the internal validity of the study and provide a solid foundation for future longitudinal investigations. Further studies conducted in different settings and involving individuals with diverse socioeconomic backgrounds and varying degrees of disease severity are needed to complement these findings. Additionally, it is important to acknowledge that other psychological and social variables known to influence happiness—such as symptoms of anxiety and depression, level of social support, and recent stressful life events—were not assessed in this study. While our groups were matched for key sociodemographic variables, the absence of these measures limits our ability to fully determine the extent to which these unmeasured factors may have contributed to the observed differences in the perception of happiness. In conclusion, individuals with COPD report significantly lower levels of happiness and life satisfaction compared to healthy peers. Our findings indicate that the psychological impact of COPD extends beyond traditional symptoms and distress, involving a marked reduction in positive affective states. Given the cross‐sectional nature of this study, these results should be viewed as observations of association, highlighting happiness as a relevant clinical outcome that warrants further longitudinal investigation to determine its potential role in disease management and long‐term quality of life. Author Contributions Layla Cristine de Toledo: conceptualization, data curation, investigation, formal analysis, writing – original draft. Cristino Carneiro Oliviera: conceptualization, methodology, validation, formal analysis, visualization, writing – review and editing. Joice Gomide Nolasco de Assis: methodology, data curation, validation, formal analysis, visualization, writing – review and editing. Júlia Márcia Pereira: methodology, data curation, validation, formal analysis, visualization, writing – review and editing. Larissa Guimarães Paiva: methodology, data curation, validation, formal analysis, visualization, writing – review and editing. Nara Batista de Sousa: methodology, data curation, validation, formal analysis, visualization, writing – review and editing. Carla Malaguti: conceptualization, methodology, validation, formal analysis, supervision, writing – review and editing. Anderson José: conceptualization, methodology, data curation, validation, formal analysis, supervision, writing – original draft. All authors have read and approved the final version of the manuscript. Funding Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) APQ‐04458‐23. Ethics Statement The study protocol followed the Helsinki Declaration and was approved by the research ethics committee of the Federal University of Juiz de Fora/MG (protocol number 6.187.583). All individuals signed a written informed consent. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement Anderson José affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.